Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
1.820
-0.010 (-0.55%)
At close: Dec 26, 2025, 4:00 PM EST
1.860
+0.040 (2.19%)
After-hours: Dec 26, 2025, 7:59 PM EST
Outlook Therapeutics Employees
Outlook Therapeutics had 23 employees as of September 30, 2024. The number of employees decreased by 1 or -4.17% compared to the previous year.
Employees
23
Change (1Y)
-1
Growth (1Y)
-4.17%
Revenue / Employee
$61,458
Profits / Employee
-$2,714,124
Market Cap
116.69M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 23 | -1 | -4.17% |
| Sep 30, 2023 | 24 | 7 | 41.18% |
| Sep 30, 2022 | 17 | 8 | 88.89% |
| Sep 30, 2021 | 9 | 1 | 12.50% |
| Sep 30, 2020 | 8 | -6 | -42.86% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
OTLK News
- 18 hours ago - Outlook Therapeutics Announces New Employment Inducement Grants - GlobeNewsWire
- 8 days ago - Outlook Therapeutics Reports Financial Results for Fiscal Year 2025 - GlobeNewsWire
- 4 weeks ago - Outlook Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD - GlobeNewsWire
- 7 weeks ago - Outlook Therapeutics Re-Submits Biologics License Application for ONS-5010 - GlobeNewsWire
- 3 months ago - Outlook Therapeutics Provides Update on Type A Meeting with FDA - GlobeNewsWire
- 4 months ago - Outlook Therapeutics to Present at the 2025 EURETINA Innovation Spotlight (EIS) - GlobeNewsWire
- 4 months ago - Outlook Therapeutics Requests Type A Meeting with FDA - GlobeNewsWire